Subscribe
Logo small
Search

Draft Critical Medicines Act - manufacturers' position.

MedExpress Team

Medexpress

Published March 12, 2025 11:09

Draft Critical Medicines Act - manufacturers' position. - Header image
Fot. Getty Images/iStockphoto
- In the current extremely dangerous geopolitical situation, this is a very important project for the security of all residents of the Union. I hope that in the course of its work it will be supplemented with a fund for critical medicines, which will actually increase their production in Europe," says Krzysztof Kopeć, president of National Drug Manufacturers, about the assumptions of the Critical Medicines Act presented on March 11 at the plenary session of the European Parliament.

- This is a strategic project that we have been waiting for a very long time, as we petitioned the European Parliament for its creation in 2022. We are glad that it has come into being, because it is the basis for further work on its completion and clarification. The EU must take bold steps to guarantee our safety for all of us," adds Grzegorz Rychwalski, vice president of National Drug Manufacturers.

Critical drugs

The EU list of critical medicines updated in 2024 includes more than 270 active substances, covering treatments for diseases such as infections, cardiovascular diseases, mental illnesses and cancer. Critical medicines are those with limited or no alternatives, and their shortage would cause serious harm to patients. In Poland...

Content locked

To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at english@medexpress.pl.

If you already have an account, please log in

Szukaj nowych pracowników

Dodaj ogłoszenie o pracę za darmo

Lub znajdź wyjątkowe miejsce pracy!

Read also